The main fields of use of robotic technology in cardiovascular medicine are endoscopic cardiac and vascular surgery, endovascular surgery, catheter-based ablation therapy for atrial fibrillation, and ...

There is a considerable clinical need for alternatives to the autologous vein and artery tissues used for vascular reconstructive surgeries such as CABG, lower limb bypass, arteriovenous shunts and ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. One person dies of cardiovascular disease (CVD) every 34 ...

Modern cardiovascular care involves human acumen, complex data and collaborative intelligence between the two. Payment models are based on well-defined tests and procedures and are baffled by the ...

Cardiovascular disease(CVD) is currently the leading cause of death globally. The World Health Organisation (WHO) reported that CVD, which encompasses all conditions linked to the heart and blood ...

New solutions for improving and managing cardiovascular health are urgently needed, but effective and worthwhile solutions often fail to make it to patients because all critical stakeholders are not ...

AngioDynamics will provide investors a deeper dive into the cardiovascular technology portfolio and strategic vision. The event will be webcast and can be accessed through the "Investors" section of ...

Carmella, 72, who had a heart attack and could not be transferred to a specialized facility, is seen waiting at Bellville Medical Center in Texas -- one of many rural ...

Researchers at Mass General Brigham Heart and Vascular Institute have developed and validated a new genetic risk test that ...

Before selecting any clinical treatment or modality, a comprehensive and also unbiased review and understanding of the clinical evidence is critical for the best patient outcomes. Three examples of ...

Diagnostic ultrasounds are a common, non-invasive way to help doctors detect internal bodily abnormalities and determine sources of pain or discomfort. Technicians use high-frequency sound waves to ...

NEW YORK (Reuters) - U.S. pharmaceutical and medical equipment maker Johnson & Johnson said on Monday it agreed to sell its Cordis vascular technology unit to Cardinal Health for $1.9 billion, ...